SCHEMBL19849337

SCHEMBL19849337

COc1ccc(-c2ccncc2NC(O)c2ccnc(Cl)c2)c(F)c1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ RPS6KA3 P51812 5/20 0.39
▸ GSK3B P49841 4/20 0.35
▸ GSK3A P49840 3/20 0.35
▸ CDK2 P24941 3/20 0.35
▸ ROCK1 Q13464 3/20 0.35
▸ CYP3A4 P08684 2/20 0.35
▸ ROCK2 O75116 1/20 0.35
▸ CYP2C9 P11712 1/20 0.35
▸ NPSR1 Q6W5P4 1/20 0.35
▸ CTSA P10619 2/20 0.35
▸ CYP17A1 P05093 2/20 0.34
▸ CYP11B1 P15538 2/20 0.34
▸ CYP11B2 P19099 2/20 0.34
▸ MAP4K4 O95819 2/20 0.34
▸ PRKCG P05129 2/20 0.34
▸ CDK1 P06493 2/20 0.34
▸ PRKACA P17612 2/20 0.34
▸ RPS6KB1 P23443 2/20 0.34
▸ MAPK1 P28482 2/20 0.34
▸ AKT1 P31749 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19849273 0.82 SLC22A12 (0.40) GSK3BGSK3ACDK2CYP11B1CYP11B2
SCHEMBL16702543 0.78 GSK3B (0.56) GSK3BGSK3A
SCHEMBL19417859 0.75 GSK3B (0.43) GSK3BGSK3AALDH1A1
SCHEMBL27415952 0.69 AMY1A (0.46) CTSACYP17A1CYP11B1CYP11B2GRM2
SCHEMBL29904245 0.69 AMY1A (0.46) CTSACYP17A1CYP11B1CYP11B2GRM2
SCHEMBL16702907 0.64 GSK3B (0.78) GSK3BGSK3A
SCHEMBL10340365 0.63 AMY1A (0.50) CYP3A4CYP2C9NPSR1GRM2ALDH1A1
SCHEMBL16702830 0.63 GSK3B (0.68) GSK3BGSK3ACDK2CDK5
SCHEMBL2005702 0.62 GPBAR1 (0.45) RPS6KA3GSK3BGSK3ACDK2ROCK1
SCHEMBL479982 0.61 CYP2D6 (0.39) ROCK1CYP3A4ROCK2MAPK1DYRK1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3066093-B9 GSK-3 INHIBITORS BRISTOL MYERS SQUIBB CO (US) 2018-02-07 — — EP disclosed
Send feedback